Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

313233343536373839

LONDON MARKET CLOSE: Stocks end volatile April on high note

29th Apr 2022 17:01

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed. Read More

TOP NEWS: AstraZeneca backs yearly outlook but quarterly profit down

29th Apr 2022 10:18

(Alliance News) - AstraZeneca PLC on Friday reported a sharp rise in first-quarter revenue, though profit declined, and the drugmaker also announced plans for a new strategic site in the US. Read More

LONDON MARKET PRE-OPEN: Strong Reckitt guidance; NatWest backs outlook

29th Apr 2022 07:50

(Alliance News) - Stock prices in London are seen opening higher on Friday, making a confident end to a tricky month for markets, which have faced Covid-19 worries in China, alongside rampant inflation and central bank monetary tightening in response. Read More

AstraZeneca wins US approval for generalised myasthenia gravis drug

28th Apr 2022 09:51

(Alliance News) - AstraZeneca PLC on Thursday said its drug Ultomiris has been approved by the US Food & Drug Administration for the treatment of adults with generalised myasthenia gravis. Read More

AstraZeneca, Daiichi Sankyo cancer drug secures US regulatory boost

27th Apr 2022 09:44

(Alliance News) - AstraZeneca PLC on Wednesday said a cancer drug it has helped develop to treat a form of breast cancer has been granted breakthrough therapy designation in the US. Read More

AstraZeneca's Tremelimumab-Imfinzi combo to get US priority review

25th Apr 2022 08:32

(Alliance News) - AstraZeneca PLC on Monday announced its candidate for unresectable liver cancer Tremelimumab has been accepted under priority review by the US Food & Drug Administration. Read More

LONDON MARKET PRE-OPEN: British Land sells Paddington Central stake

25th Apr 2022 07:50

(Alliance News) - Stock prices in Europe are seen opening lower on Monday, with a grim Covid-19 situation in China adding to a mountain of worries for equities investors, which included hawkish comments made by Federal Reserve Chair Jerome Powell late last week. Read More

UK earnings, trading statements calendar - next 7 days

22nd Apr 2022 16:03

Read More

UK shareholder meetings calendar - next 7 days

22nd Apr 2022 16:01

Read More

AstraZeneca says no severe virus cases or deaths after taking antibody

21st Apr 2022 06:01

(Alliance News) - AstraZeneca PLC late Wednesday said a clinical trial found its Evusheld antibody therapy markedly reduced the risk of developing symptomatic Covid-19. Read More

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

20th Apr 2022 10:00

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause. Read More

LONDON BROKER RATINGS: Prudential and CRH get upgrades, ITV cut

19th Apr 2022 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Thursday last week: Read More

AstraZeneca's Enhertu wins priority review by FDA for lung cancer

19th Apr 2022 08:17

(Alliance News) - AstraZeneca PLC on Tuesday said its lung cancer antibody drug conjugate Enhertu has received priority review from the Food & Drug Administration in the US. Read More

LONDON MARKET PRE-OPEN: Spectris launches GBP300 million share buyback

19th Apr 2022 07:44

(Alliance News) - Stock trading in London is set for a downbeat return following the long Easter weekend, with traders mulling global growth prospects. Read More

LONDON BROKER RATINGS: BofA raises Rightmove; Berenberg cuts Bunzl

14th Apr 2022 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon: Read More

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

12th Apr 2022 10:11

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

LONDON BROKER RATINGS: Jefferies cuts TI Fluid, PageGroup, Energean

7th Apr 2022 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

AstraZeneca notes positive follow-up results for Ultomiris

6th Apr 2022 20:57

(Alliance News) - AstraZeneca PLC said on Wednesday new, prolonged follow-up results from the phase three Champion-MG trial showed that Ultomiris demonstrated long-term efficacy in adults with generalised myasthenia gravis. Read More

LONDON BROKER RATINGS: Berenberg cuts Polymetal and raises Hochschild

6th Apr 2022 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

AstraZeneca's AZD8233 shows positive results for hypercholesterolemia

5th Apr 2022 07:00

(Alliance News) - AstraZeneca PLC announced positive results from its Etesian phase IIb trial on Monday, which met its primary and secondary endpoints. Read More

313233343536373839
FTSE 100 Latest
Value8,333.64
Change57.98